Novartis Weighs Alcon Spinoff

Novartis said it was considering options for its ailing eye-care business Alcon, one year into a slower-than-expected turnaround for that business.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news
More News: Pharmaceuticals